Items where authors include "Kenealy, N."

Article

Nanchahal, J., Ball, C., Rombach, I. orcid.org/0000-0003-3464-3867 et al. (9 more authors) (2022) Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial. The Lancet Rheumatology, 4 (6). E407-E416. ISSN 2665-9913